Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Cheng Huang

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
American Journal of Cancer Research|December 7, 2023
Advancing breast cancer subtyping: optimizing immunohistochemical staining classification with insights from real-world Taiwanese dataYu-Tien Chang, Zhi-Jie Hong, Jyh-Cherng Yu, et al.
The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.
Frontiers in Oncology|September 1, 2023
Prevalence of <i>PIK3CA</i> mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysisTa-Chung Chao, Yi-Fang Tsai, Chun-Yu Liu, et al.
Breast Cancer (Tokyo, Japan)|December 9, 2023
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in TaiwanBo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, et al.
Journal of the Chinese Medical Association : JCMA|October 13, 2021
Clinicopathological characteristics and treatment outcomes of luminal B1 breast cancer in TaiwanBo-Fang Chen, Yi-Fang Tsai, Chi-Cheng Huang, et al.
Journal of the Chinese Medical Association : JCMA|November 11, 2024
Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2- breast cancerYun-Chieh Kao, Yi-Fang Tsai, Shih-Che Shen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 28, 2017
Identification of genes and pathways related to lymphovascular invasion in breast cancer patients: A bioinformatics analysis of gene expression profilesSukhontip Klahan, Henry Sung-Ching Wong, Shih-Hsin Tu, et al.
Annals of Surgical Oncology|February 28, 2022
Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast CancersChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Translational Oncology|September 15, 2023
Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancersLing-Ming Tseng, Chi-Cheng Huang, Yi-Fang Tsai, et al.
International Journal of Cancer|August 12, 2018
DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpointWei-Hwa Lee, Li-Ching Chen, Chia-Jung Lee, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
American Journal of Cancer Research|December 7, 2023
Advancing breast cancer subtyping: optimizing immunohistochemical staining classification with insights from real-world Taiwanese dataYu-Tien Chang, Zhi-Jie Hong, Jyh-Cherng Yu, et al.
The Oncologist|September 2, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: Prognostic effect of proton pump inhibitor useBo-Fang Chen, Jiun-I Lai, Yi-Fang Tsai, et al.
Frontiers in Oncology|September 1, 2023
Prevalence of <i>PIK3CA</i> mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysisTa-Chung Chao, Yi-Fang Tsai, Chun-Yu Liu, et al.
Breast Cancer (Tokyo, Japan)|December 9, 2023
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in TaiwanBo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, et al.
Journal of the Chinese Medical Association : JCMA|October 13, 2021
Clinicopathological characteristics and treatment outcomes of luminal B1 breast cancer in TaiwanBo-Fang Chen, Yi-Fang Tsai, Chi-Cheng Huang, et al.
Journal of the Chinese Medical Association : JCMA|November 11, 2024
Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2- breast cancerYun-Chieh Kao, Yi-Fang Tsai, Shih-Che Shen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 28, 2017
Identification of genes and pathways related to lymphovascular invasion in breast cancer patients: A bioinformatics analysis of gene expression profilesSukhontip Klahan, Henry Sung-Ching Wong, Shih-Hsin Tu, et al.
Annals of Surgical Oncology|February 28, 2022
Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast CancersChi-Cheng Huang, Yi-Fang Tsai, Chun-Yu Liu, et al.
Translational Oncology|September 15, 2023
Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancersLing-Ming Tseng, Chi-Cheng Huang, Yi-Fang Tsai, et al.
International Journal of Cancer|August 12, 2018
DNA primase polypeptide 1 (PRIM1) involves in estrogen-induced breast cancer formation through activation of the G2/M cell cycle checkpointWei-Hwa Lee, Li-Ching Chen, Chia-Jung Lee, et al.
Pageof 15